Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective study

Future Oncology, Ahead of Print.

Source: Future Oncology - October 10, 2018 Category: Cancer & Oncology Authors: Ralph Boccia Robert B Geller Neil Clendeninn Thomas Ottoboni Source Type: research